These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15597683)

  • 21. [Cell electrophoretic studies in candida mycoses].
    Kaben U; Jenssen HL; Köhler H; Westphal HJ; Mix E
    Dermatol Monatsschr; 1976 Feb; 162(2):117-20. PubMed ID: 782938
    [No Abstract]   [Full Text] [Related]  

  • 22. Low dose of Concanavalin-A enhances innate immune response and prevents liver injury in mice infected with Candida albicans.
    Conchon-Costa I; Loyola W; Gaziri LC; Custódio LA; Felipe I
    FEMS Immunol Med Microbiol; 2007 Apr; 49(3):330-6. PubMed ID: 17284281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host defence against C. albicans infections in IgH transgenic mice with V(H) derived from a natural anti-keratin antibody.
    Li W; Fu M; An JG; Xing Y; Zhang P; Zhang X; Wang YC; Li CX; Tian R; Su WJ; Guan HH; Wang G; Gao TW; Han H; Liu YF
    Cell Microbiol; 2007 Feb; 9(2):306-15. PubMed ID: 16925788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influence of intensity of Trichinella invasion on the phagocytosis of Candida albicans by mice macrophages].
    Szkudlinski J
    Wiad Parazytol; 2001; 47(4):661-6. PubMed ID: 16886407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The relationship between Candida albicans colonization indices and the presence of specific antibodies in non-neutropenic intensive care unit patients].
    Eren A; Aydoğan S; Kalkanci A; Kuştimur S
    Mikrobiyol Bul; 2007 Apr; 41(2):253-9. PubMed ID: 17682712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA.
    Dimitrova P; Yordanov M; Danova S; Ivanovska N
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):231-6. PubMed ID: 18507679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candida albicans-secreted lipase induces injury and steatosis in immune and parenchymal cells.
    Paraje MG; Correa SG; Renna MS; Theumer M; Sotomayor CE
    Can J Microbiol; 2008 Aug; 54(8):647-59. PubMed ID: 18772927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both viable and killed Candida albicans cells induce in vitro production of TNF-alpha and IFN-gamma in murine cells through a TLR2-dependent signalling.
    Murciano C; Yáñez A; Gil ML; Gozalbo D
    Eur Cytokine Netw; 2007 Mar; 18(1):38-43. PubMed ID: 17400537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Candida albicans with a commercially prepared germ-tube solution.
    Potter L; Papasian CJ
    Clin Lab Sci; 1991; 4(2):121-2. PubMed ID: 10149414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis.
    Moran GP; MacCallum DM; Spiering MJ; Coleman DC; Sullivan DJ
    Mol Microbiol; 2007 Nov; 66(4):915-29. PubMed ID: 17927699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of protein expression in macrophages in response to Candida albicans infection.
    Shin YK; Kim KY; Paik YK
    Mol Cells; 2005 Oct; 20(2):271-9. PubMed ID: 16267403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of anti-Candida activity of macrophages by a quorum-sensing molecule, farnesol, through induction of oxidative stress.
    Abe S; Tsunashima R; Iijima R; Yamada T; Maruyama N; Hisajima T; Abe Y; Oshima H; Yamazaki M
    Microbiol Immunol; 2009 Jun; 53(6):323-30. PubMed ID: 19493200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation in response to Candida.
    Domer JE; Garner RE
    Immunol Ser; 1989; 47():293-317. PubMed ID: 2490080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity to Candida albicans mediated by human serum and peripheral blood mononuclear cells.
    Bliss JM; Laforce-Nesbitt SS
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):452-60. PubMed ID: 16553821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of aging on murine neutrophil and macrophage function against Candida albicans.
    Murciano C; Yáñez A; O'Connor JE; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):214-21. PubMed ID: 18445021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
    Zhang H; Chen H; Niu J; Wang Y; Xie L
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine modulation of specific and nonspecific immunity to Candida albicans.
    Romani L
    Mycoses; 1999; 42 Suppl 2():45-8. PubMed ID: 10865903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Animal experiment studies on the immunity in Candida albicans infection].
    Fegeler K; Macher E; Nolting S
    Mykosen; 1978 May; 21(5):127-37 cont. PubMed ID: 349377
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK.
    Payne S; Gibson G; Wynne A; Hudspith B; Brostoff J; Tuohy K
    Curr Issues Intest Microbiol; 2003 Mar; 4(1):1-8. PubMed ID: 12691257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.